Replies to post #279260 on Anavex Life Sciences Corp (AVXL)

[Doc328]

I want Eisai now more than ever. Come on Harrald get Charlie to move

Biogen and Eisai collaborate on aducanumab. Hampel will be all in on aducanumab.

Biogen licensed aducanumab from Neurimmune under a collaborative development and license agreement. Since October 2017 Biogen and Eisai have collaborated on the development and commercialization of aducanumab globally.

[paheron]

Google old Harry and look at his Total compensation.